BRIEF-Audentes Therapeutics announces FDA clearance of investigational new drug application for AT342
* Audentes Therapeutics announces FDA clearance of investigational new drug application for AT342 to treat Crigler-Najjar Syndrome [Source]
Publication Date:Origin: reuters.com
Category: governmentFilingsNews
Topics: AT342, application, clearance, announces, Therapeutics, Syndrome, treat Crigler-Najjar, of investigational, Audentes, investigational, BRIEF-Audentes
Source: http://feeds.reuters.com/~r/reuters/governmentfilingsNews/~3/ziWF4P2Eyi4/idUSASB0AXWF